Akihiro Hosoi Selected Research

Calreticulin

7/2017

Intravenous dendritic cell administration enhances suppression of lung metastasis induced by carbon-ion irradiation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Akihiro Hosoi Research Topics

Disease

21	Neoplasms (Cancer) 04/2023 - 05/2008
4	Experimental Melanoma 01/2018 - 04/2014
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 03/2016
2	Stomach Neoplasms (Stomach Cancer) 01/2020 - 05/2018
2	Lung Neoplasms (Lung Cancer) 01/2017 - 03/2016
1	Esophageal Neoplasms (Esophageal Cancer) 01/2021
1	Necrosis 01/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018
1	Neoplasm Metastasis (Metastasis) 07/2017
1	Carcinoma (Carcinomatosis) 01/2017
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2017
1	Adenocarcinoma 01/2017
1	Testicular Neoplasms (Testicular Cancer) 10/2015
1	Infections 05/2008

Drug/Important Bio-Agent (IBA)

5	RNA (Ribonucleic Acid)IBA 10/2020 - 01/2017
4	Immune Checkpoint InhibitorsIBA 10/2020 - 01/2018
4	AntigensIBA 01/2017 - 06/2008
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 10/2015
2	Programmed Cell Death 1 ReceptorIBA 10/2020 - 01/2020
2	VaccinesIBA 01/2018 - 03/2016
2	AntibodiesIBA 01/2018 - 10/2015
2	Messenger RNA (mRNA)IBA 02/2017 - 06/2008
2	Cytostatic AgentsIBA 03/2015 - 01/2015
2	Indicators and Reagents (Reagents)IBA 03/2015 - 01/2015
2	InterferonsIBA 03/2015 - 07/2012
1	taxaneIBA 01/2021
1	PlatinumIBA 01/2021
1	Fluorouracil (Carac)FDA LinkGeneric 01/2021
1	Small Cytoplasmic RNAIBA 10/2020
1	Interleukin-17 (Interleukin 17)IBA 10/2020
1	Everolimus FDA Link 01/2020
1	Sunitinib (Sutent)FDA Link 01/2020
1	Zoledronic Acid (Zometa)FDA Link 01/2020
1	Complement System Proteins (Complement)IBA 01/2020
1	temsirolimus FDA Link 01/2020
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2020
1	Immunologic Factors (Immunomodulators)IBA 01/2020
1	pembrolizumabIBA 01/2020
1	Type 4 Fibroblast Growth Factor ReceptorIBA 05/2018
1	Protein Subunit VaccinesIBA 01/2018
1	ChemokinesIBA 01/2018
1	CytokinesIBA 01/2018
1	CarbonIBA 07/2017
1	CalreticulinIBA 07/2017
1	Complementary DNA (cDNA)IBA 02/2017
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2017
1	Cysteine (L-Cysteine)FDA Link 10/2015
1	AutoantibodiesIBA 10/2015
1	EpitopesIBA 10/2015
1	Proteins (Proteins, Gene)FDA Link 10/2015
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2015
1	Neutralizing AntibodiesIBA 01/2015
1	Cyclin-Dependent Kinase Inhibitor p27IBA 01/2015
1	S-Phase Kinase-Associated Proteins (Skp1 Protein)IBA 01/2015
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2015
1	Neoplasm Antigens (Tumor Antigens)IBA 04/2014
1	Monoclonal AntibodiesIBA 07/2012
1	Peptides (Polypeptides)IBA 05/2008

Therapy/Procedure

11	Immunotherapy 04/2023 - 01/2009
11	Therapeutics 01/2021 - 01/2009
1	Drug Therapy (Chemotherapy) 01/2021
1	Transplantation 05/2018
1	Heavy Ion Radiotherapy 07/2017
1	Radiotherapy 07/2017
1	Intravenous Injections 08/2015